Atorvastatin induces autophagic cell death in prostate cancer cells in vitro

He,Zhenhua; Yuan,Jingmin; Qi,Ping; Zhang,Lixiu; Wang,Zhiping

doi:10.3892/mmr.2015.3334

June-2015 Volume 11 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

June-2015 Volume 11 Issue 6

Full Size Image

Article

Atorvastatin induces autophagic cell death in prostate cancer cells in vitro

Authors:
- Zhenhua He
- Jingmin Yuan
- Ping Qi
- Lixiu Zhang
- Zhiping Wang
View Affiliations / Copyright

Affiliations: School of Life Sciences, Lanzhou University, Lanzhou, Gansu 730000, P.R. China, Department of Pain, The Second Hospital of Lanzhou University, Lanzhou, Gansu 730030, P.R. China, Institute of Urology and Key Laboratory of Urological Diseases in Gansu, The Second Hospital of Lanzhou University, Lanzhou, Gansu 730030, P.R. China
Pages: 4403-4408
|
Published online on: February 11, 2015

https://doi.org/10.3892/mmr.2015.3334
Expand metrics +

Abstract

Athough it is well known that apoptosis contributes to cancer cell death, the role of autophagy in cancer cell death has remained in dispute. Atorvastatin has been suggested to exhibit anti-cancer effects. The present study aimed to examine atorvastatin-induced autophagy-associated cell death and the autophagy‑associated gene expression profile in the PC3 prostate carcinoma cell line. The atorvastatin‑induced process of autophagy in PC3 cells was determined via evaluation of the cellular expression levels of autophagosomal marker light-chain-3 (LC3)‑II, using immunoblotting and counting of green fluorescent protein (GFP)‑LC3-transfected autophagic cells. Apoptosis was examined by terminal deoxynucleotidyl transferase dUTP nick end labeling assay and an MTT assay was used to evaluate cell viability. Total RNA of PC3 cells was isolated for characterization of the gene expression profile following atorvastatin treatment. Atorvastatin treatment of PC3 cells for 24 h increased the expression of green fluorescent protein‑LC3‑II by >25%, and expression continued for >72 h, while apoptosis was not significantly induced within this time period. Four genes associated with the autophagy machinery were also significantly upregulated. In the presence of atorvastatin, autophagy may be unable to abrogate cell damage and may therefore contribute to cellular dysfunction, leading to autophagic/type II programmed cell death. In response to atorvastatin treatment, the expression of genes involved in autophagic mediating pathways may have a role in tumor suppression.

View Figures

View References

1	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
2	Siegel R, DeSantis C, Virgo K, et al: Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
3	Sun F, Oyesanmi O, Fontanarosa J, Reston J, Guzzo T and Schoelles K: Therapies for clinically localized prostate cancer: Update of a 2008 systematic review. AHRQ Comparative Effectiveness Reviews: 15-EHC004-EF. 2014
4	Dozmorov MG, Hurst RE, Culkin DJ, et al: Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cells. Prostate. 69:1077–1090. 2009. View Article : Google Scholar : PubMed/NCBI
5	An J, Chervin AS, Nie A, Ducoff HS and Huang Z: Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor. Oncogene. 26:652–661. 2007. View Article : Google Scholar
6	Marcelli M, Marani M, Li X, et al: Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members and caspase activation. Prostate. 42:260–273. 2000. View Article : Google Scholar : PubMed/NCBI
7	Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R and Collins R; Prospective Studies Collaboration: Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 370:1829–1839. 2007. View Article : Google Scholar : PubMed/NCBI
8	Sassano A and Platanias LC: Statins in tumor suppression. Cancer Lett. 260:11–19. 2008. View Article : Google Scholar : PubMed/NCBI
9	Chan KK, Oza AM and Siu LL: The statins as anticancer agents. Clin Cancer Res. 9:10–19. 2003.PubMed/NCBI
10	Parikh A, Childress C, Deitrick K, Lin Q, Rukstalis D and Yang W: Statin-induced autophagy by inhibition of geranylgeranyl biosynthesis in prostate cancer PC3 cells. Prostate. 70:971–981. 2010. View Article : Google Scholar : PubMed/NCBI
11	Schleicher SM, Moretti L, Varki V and Lu B: Progress in the unraveling of the endoplasmic reticulum stress/autophagy pathway and cancer: implications for future therapeutic approaches. Drug Resist Updat. 13:79–86. 2010. View Article : Google Scholar : PubMed/NCBI
12	Park WH, Kim ES, Kim BK and Lee YY: Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis. Int J Oncol. 23:197–204. 2003.PubMed/NCBI
13	Robinson SM, Tsueng G, Sin J, et al: Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers. PLoS Pathog. 10:e10040452014. View Article : Google Scholar : PubMed/NCBI
14	Gong JS and Kim GJ: The role of autophagy in the placenta as a regulator of cell death. Clin Exp Reprod Med. 41:97–107. 2014. View Article : Google Scholar : PubMed/NCBI
15	Hannigan AM and Gorski SM: Macroautophagy: the key ingredient to a healthy diet? Autophagy. 5:140–151. 2009. View Article : Google Scholar
16	Nishino I: Autophagic vacuolar myopathy. Semin Pediatr Neurol. 13:90–95. 2006. View Article : Google Scholar : PubMed/NCBI
17	Gozuacik D and Kimchi A: Autophagy and cell death. Curr Top Dev Biol. 78:217–245. 2007. View Article : Google Scholar : PubMed/NCBI
18	Yang ZJ, Chee CE, Huang S and Sinicrope F: Autophagy modulation for cancer therapy. Cancer Biol Ther. 11:169–176. 2011. View Article : Google Scholar : PubMed/NCBI
19	Yue Z, Jin S, Yang C, Levine AJ and Heintz N: Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA. 100:15077–15082. 2003. View Article : Google Scholar : PubMed/NCBI
20	Park MA, Zhang G, Martin AP, et al: Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. Cancer Biol Ther. 7:1648–1662. 2008. View Article : Google Scholar : PubMed/NCBI
21	Katayama M, Kawaguchi T, Berger MS and Pieper RO: DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ. 14:548–558. 2007. View Article : Google Scholar
22	Cao C, Subhawong T, Albert JM, et al: Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Cancer Res. 66:10040–10047. 2006. View Article : Google Scholar : PubMed/NCBI
23	Duffy A, Le J, Sausville E and Emadi A: Autophagy modulation: a target for cancer treatment development. Cancer Chemother Pharmacol. Nov 25–2014.Epub ahead of print. PubMed/NCBI
24	Song X, Liu H, Wang X, Li Z and Huang C: Atorvastatin combined with poly-unsaturated fatty acid confers better improvement of dyslipidemia and endothelium function. Lipids Health Dis. 13:1862014. View Article : Google Scholar : PubMed/NCBI
25	Pearson T, Ballantyne C, Sisk C, Shah A, Veltri E and Maccubbin D: Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels. Am J Cardiol. 99:1706–1713. 2007. View Article : Google Scholar : PubMed/NCBI
26	Yang PM, Liu YL, Lin YC, Shun CT, Wu MS and Chen CC: Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. Cancer Res. 70:7699–7709. 2010. View Article : Google Scholar : PubMed/NCBI
27	Heymann D: Autophagy: A protective mechanism in response to stress and inflammation. Curr Opin Investig Drugs. 7:443–450. 2006.PubMed/NCBI
28	He Z, Zhang Y, Mehta SK, Pierson DL, Wu H and Rohde LH: Expression profile of apoptosis related genes and radio-sensitivity of prostate cancer cells. J Radiat Res. 52:743–751. 2011. View Article : Google Scholar : PubMed/NCBI
29	Zhu K, Dunner K Jr and McConkey DJ: Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene. 29:451–462. 2010. View Article : Google Scholar :
30	Umemiya-Shirafuji R, Matsuo T, Liao M, Boldbaatar D, Battur B, Suzuki H and Fujisaki K: Increased expression of ATG genes during nonfeeding periods in the tick Haemaphysalis longicornis. Autophagy. 6:473–481. 2010. View Article : Google Scholar : PubMed/NCBI
31	Aguilera MO, Berón W and Colombo MI: The actin cytoskeleton participates in the early events of autophagosome formation upon starvation induced autophagy. Autophagy. 8:1590–1603. 2012. View Article : Google Scholar : PubMed/NCBI
32	Levine B: Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell. 120:159–162. 2005.PubMed/NCBI
33	Yu C, Wang L, Lv B, et al: TMEM74, a lysosome and autophagosome protein, regulates autophagy. Biochem Biophys Res Commun. 369:622–629. 2008. View Article : Google Scholar : PubMed/NCBI
34	Kirkin V, McEwan DG, Novak I and Dikic I: A role for ubiquitin in selective autophagy. Mol Cell. 34:259–269. 2009. View Article : Google Scholar : PubMed/NCBI
35	Behrends C, Sowa ME, Gygi SP and Harper JW: Network organization of the human autophagy system. Nature. 466:68–76. 2010. View Article : Google Scholar : PubMed/NCBI
36	Levine B and Yuan J: Autophagy in cell death: an innocent convict? J Clin Invest. 115:2679–2688. 2005. View Article : Google Scholar : PubMed/NCBI
37	Berry DL and Baehrecke EH: Autophagy functions in programmed cell death. Autophagy. 4:359–360. 2008. View Article : Google Scholar : PubMed/NCBI
38	Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB and Tsujimoto Y: Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol. 6:1221–1228. 2004. View Article : Google Scholar : PubMed/NCBI
39	Espert L, Denizot M, Grimaldi M, et al: Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest. 116:2161–2172. 2006. View Article : Google Scholar : PubMed/NCBI
40	Chen ZH, Lam HC, Jin Y, et al: Autophagy protein microtubule-associated protein 1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smoke-induced emphysema. Proc Natl Acad Sci USA. 107:18880–18885. 2010. View Article : Google Scholar : PubMed/NCBI
41	Weber JD, Jeffers JR, Rehg JE, et al: p53-independent functions of the p19(ARF) tumor suppressor. Genes Dev. 14:2358–2365. 2000. View Article : Google Scholar : PubMed/NCBI
42	Matsuoka M, Kurita M, Sudo H, Mizumoto K, Nishimoto I and Ogata E: Multiple domains of the mouse p19ARF tumor suppressor are involved in p53-independent apoptosis. Biochem Biophys Res Commun. 301:1000–1010. 2003. View Article : Google Scholar : PubMed/NCBI
43	Paliwal S, Pande S, Kovi RC, Sharpless NE, Bardeesy N and Grossman SR: Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis. Mol Cell Biol. 26:2360–2372. 2006. View Article : Google Scholar : PubMed/NCBI
44	Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H and Levine B: Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 402:672–676. 1999. View Article : Google Scholar : PubMed/NCBI